Optical Coherence Tomography (OCT) Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$4000
Buy Report Download FREE Resources

Published: May 20, 2024 Report Code: GDME1746EPD-ST

Select Item

Optical Coherence Tomography Pipeline Market Report Overview

Optical coherence tomography (OCT) equipment allows for the imaging and measurement of retinal thickness. The optical coherence tomography pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Territories ·        United States

·        Europe

·        China

·        Japan

·        South Africa
Key Regulatory Paths ·        510 (K)

·        CE

·        NMPA

·        Ninsho

·        UKCA

·        ICAC
Leading Companies ·        Canon USA

·        Compact Imaging Inc.

·        Kubota Vision Inc

·        Leica Microsystems GmbH

·        Lumedica Inc
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Optical Coherence Tomography Pipeline Market Segmentation by Territories

A few of the key territories with the optical coherence tomography pipeline market are the United States, Europe, China, Japan, and South Africa among others. As of May 2024, the United States (US) accounts for the highest number of pipeline products.

Optical Coherence Tomography Pipeline Market Analysis by Territories, 2024 (%)

Optical Coherence Tomography Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Optical Coherence Tomography Pipeline Market

Download a Free Report Sample

Optical Coherence Tomography Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the optical coherence tomography pipeline products market are 510 (K), CE, NMPA, Ninsho, UKCA, and ICAC among others. As of May 2024, 510(k) is the most followed pathway for pipeline products in the optical coherence tomography market.

Optical coherence tomography Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Optical coherence tomography Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Optical Coherence Tomography Pipeline Market

Download a Free Report Sample

Optical Coherence Tomography Pipeline Market – Competitive Landscape

A few of the key companies associated with the optical coherence tomography pipeline market are Canon USA, Compact Imaging Inc., Kubota Vision Inc., Leica Microsystems GmbH, and Lumedica Inc., among others.

Canon USA: Canon USA Inc is a Technologty and Communication company that provides digital printing and software services. The Company is Headquartered in Melville, New York, The U.S.

Compact Imaging Inc.: Compact Imaging Inc. (Compact Imaging) has developed and patented a miniature optical sensor technology called MRO for the biometric security and mobile health monitoring market. Compact Imaging is headquartered in Mountain View, California, the US.

Optical Coherence Tomography Pipeline Market Analysis by Companies, 2024

Optical Coherence Tomography Pipeline Market Analysis by Companies, 2024
Buy the Full Report for More Company Insights into the Optical Coherence Tomography Pipeline Market
Download a Free Report Sample

Segments Covered in the Report

Optical Coherence Tomography Pipeline Market Territories Outlook (2024)

  • United States
  • Europe
  • China
  • Japan
  • South Africa

Optical Coherence Tomography Pipeline Market Regulatory Paths Outlook (2024)

  • 510 (K)
  • CE
  • NMPA
  • Ninsho
  • UKCA
  • ICAC

Scope

This report provides:

  • Extensive coverage of the optical coherence tomography under development.

  • Exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.

  • Reviews of major players involved in the development of optical coherence tomography and lists all their pipeline projects.

  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.

  • Key clinical trial data of ongoing clinical trials specific to pipeline products.

  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.

  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.

  • Identify and understand important and diverse types of optical coherence tomography under development.

  • Develop market-entry and market-expansion strategies.

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.

  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Brown University
Canon USA Inc
Columbia University
Compact Imaging Inc.
Costruzioni Strumenti Oftalmici Cso Srl
Digital Diagnostics Inc
Duke University
George Washington University
Heidelberg Engineering GmbH
Kubota Vision Inc
Leica Microsystems GmbH
LighTopTech Corp
Lumedica Inc
Massachusetts General Hospital
MicroPort Scientific Corp
Moorfields Eye Hospital NHS Foundation Trust
Myriad Advanced Technologies LLC
Nippon Telegraph and Telephone Corp
Notal Vision Inc
Opticent Inc
OptoQuest Inc
Optos Plc
OptoVibronex LLC
Optovue Inc
Oregon Health & Science University
Physical Sciences Inc
Rowiak GmbH
Singapore Eye Research Institute
Sinoora Inc.
The University of Texas at Austin Division of Housing and Food Service
Theia Imaging LLC
TowardPi Medical Technology Ltd
Tupai (Beijing) Medical Technology Co Ltd
University of California Berkeley
University of Illinois at Chicago
University of Liverpool
University of Louisville
University of Pittsburgh
University of Rochester
Vanderbilt University

Table of Contents

1 Table of Contents 3

1.1 List of Tables 5

1.2 List of Figures 9

2 Introduction 10

2.1 Optical Coherence Tomography (OCT) Overview 10

3 Products under Development 11

3.1 Optical Coherence Tomography (OCT) – Pipeline Products by Stage of Development 11

3.2 Optical Coherence Tomography (OCT) – Pipeline Products by Territory 12

3.3 Optical Coherence Tomography (OCT) – Pipeline Products by Regulatory Path 13

3.4 Optical Coherence Tomography (OCT) – Pipeline Products by Estimated Approval Date 14

3.5 Optical Coherence Tomography (OCT) – Ongoing Clinical Trials 15

4 Optical Coherence Tomography (OCT) – Pipeline Products under Development by Companies 16

4.1 Optical Coherence Tomography (OCT) Companies – Pipeline Products by Stage of Development 16

4.2 Optical Coherence Tomography (OCT) – Pipeline Products by Stage of Development 18

5 Optical Coherence Tomography (OCT) Companies and Product Overview 20

5.1 Brown University Company Overview 20

5.1.1 Brown University Pipeline Products & Ongoing Clinical Trials Overview 20

5.2 Canon USA Inc Company Overview 22

5.2.1 Canon USA Inc Pipeline Products & Ongoing Clinical Trials Overview 22

5.3 Columbia University Company Overview 23

5.3.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 23

5.4 Compact Imaging Inc. Company Overview 24

5.4.1 Compact Imaging Inc. Pipeline Products & Ongoing Clinical Trials Overview 24

5.5 Costruzioni Strumenti Oftalmici Cso Srl Company Overview 25

5.5.1 Costruzioni Strumenti Oftalmici Cso Srl Pipeline Products & Ongoing Clinical Trials Overview 25

5.6 Digital Diagnostics Inc Company Overview 26

5.6.1 Digital Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 26

5.7 Duke University Company Overview 27

5.7.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 27

5.8 George Washington University Company Overview 33

5.8.1 George Washington University Pipeline Products & Ongoing Clinical Trials Overview 33

5.9 Heidelberg Engineering GmbH Company Overview 34

5.9.1 Heidelberg Engineering GmbH Pipeline Products & Ongoing Clinical Trials Overview 34

5.10 Kubota Vision Inc Company Overview 36

5.10.1 Kubota Vision Inc Pipeline Products & Ongoing Clinical Trials Overview 36

5.11 Leica Microsystems GmbH Company Overview 39

5.11.1 Leica Microsystems GmbH Pipeline Products & Ongoing Clinical Trials Overview 39

5.12 LighTopTech Corp Company Overview 41

5.12.1 LighTopTech Corp Pipeline Products & Ongoing Clinical Trials Overview 41

5.13 Lumedica Inc Company Overview 42

5.13.1 Lumedica Inc Pipeline Products & Ongoing Clinical Trials Overview 42

5.14 Massachusetts General Hospital Company Overview 44

5.14.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 44

5.15 MicroPort Scientific Corp Company Overview 45

5.15.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 45

5.16 Moorfields Eye Hospital NHS Foundation Trust Company Overview 49

5.16.1 Moorfields Eye Hospital NHS Foundation Trust Pipeline Products & Ongoing Clinical Trials Overview 49

5.17 Myriad Advanced Technologies LLC Company Overview 50

5.17.1 Myriad Advanced Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 50

5.18 Nippon Telegraph and Telephone Corp Company Overview 51

5.18.1 Nippon Telegraph and Telephone Corp Pipeline Products & Ongoing Clinical Trials Overview 51

5.19 Notal Vision Inc Company Overview 52

5.19.1 Notal Vision Inc Pipeline Products & Ongoing Clinical Trials Overview 52

5.20 Opticent Inc Company Overview 56

5.20.1 Opticent Inc Pipeline Products & Ongoing Clinical Trials Overview 56

5.21 OptoQuest Inc Company Overview 58

5.21.1 OptoQuest Inc Pipeline Products & Ongoing Clinical Trials Overview 58

5.22 Optos Plc Company Overview 59

5.22.1 Optos Plc Pipeline Products & Ongoing Clinical Trials Overview 59

5.23 OptoVibronex LLC Company Overview 62

5.23.1 OptoVibronex LLC Pipeline Products & Ongoing Clinical Trials Overview 62

5.24 Optovue Inc Company Overview 63

5.24.1 Optovue Inc Pipeline Products & Ongoing Clinical Trials Overview 63

5.25 Oregon Health & Science University Company Overview 64

5.25.1 Oregon Health & Science University Pipeline Products & Ongoing Clinical Trials Overview 64

5.26 Physical Sciences Inc Company Overview 65

5.26.1 Physical Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 65

5.27 Rowiak GmbH Company Overview 66

5.27.1 Rowiak GmbH Pipeline Products & Ongoing Clinical Trials Overview 66

5.28 Singapore Eye Research Institute Company Overview 67

5.28.1 Singapore Eye Research Institute Pipeline Products & Ongoing Clinical Trials Overview 67

5.29 Sinoora Inc. Company Overview 68

5.29.1 Sinoora Inc. Pipeline Products & Ongoing Clinical Trials Overview 68

5.30 The University of Texas at Austin Division of Housing and Food Service Company Overview 69

5.30.1 The University of Texas at Austin Division of Housing and Food Service Pipeline Products & Ongoing Clinical Trials Overview 69

5.31 Theia Imaging LLC Company Overview 70

5.31.1 Theia Imaging LLC Pipeline Products & Ongoing Clinical Trials Overview 70

5.32 TowardPi Medical Technology Ltd Company Overview 74

5.32.1 TowardPi Medical Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview 74

5.33 Tupai (Beijing) Medical Technology Co Ltd Company Overview 75

5.33.1 Tupai (Beijing) Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 75

5.34 University of California Berkeley Company Overview 76

5.34.1 University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview 76

5.35 University of Illinois at Chicago Company Overview 77

5.35.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 77

5.36 University of Liverpool Company Overview 78

5.36.1 University of Liverpool Pipeline Products & Ongoing Clinical Trials Overview 78

5.37 University of Louisville Company Overview 79

5.37.1 University of Louisville Pipeline Products & Ongoing Clinical Trials Overview 79

5.38 University of Pittsburgh Company Overview 80

5.38.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 80

5.39 University of Rochester Company Overview 81

5.39.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 81

5.40 Vanderbilt University Company Overview 82

5.40.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 82

6 Optical Coherence Tomography (OCT)- Recent Developments 83

6.1 Apr 23, 2024: Topcon Receives Additional FDA 510(k) Clearance for 3D Optical Coherence Tomography (Maestro2) 83

6.2 Nov 15, 2023: Topcon Medical Systems Receives 510(K) Clearance For Maestro2 83

6.3 Nov 05, 2023: Heidelberg Engineering Receives Additional 510(K) Clearance for Spectralis HRA+OCT 83

7 Appendix 85

7.1 Methodology 85

7.2 About GlobalData 88

7.3 Contact Us 88

7.4 Disclaimer 88

Table

Optical Coherence Tomography (OCT) – Pipeline Products by Stage of Development 11

Optical Coherence Tomography (OCT) – Pipeline Products by Territory 12

Optical Coherence Tomography (OCT) – Pipeline Products by Regulatory Path 13

Optical Coherence Tomography (OCT) – Pipeline Products by Estimated Approval Date 14

Optical Coherence Tomography (OCT) – Ongoing Clinical Trials 15

Optical Coherence Tomography (OCT) Companies – Pipeline Products by Stage of Development 16

Optical Coherence Tomography (OCT) – Pipeline Products by Stage of Development 18

Brown University Pipeline Products & Ongoing Clinical Trials Overview 20

Optical Coherence Tomography – Neurodegenerative Diseases – Product Status 20

Optical Coherence Tomography – Neurodegenerative Diseases – Product Description 21

Canon USA Inc Pipeline Products & Ongoing Clinical Trials Overview 22

SPOCT HR – Product Status 22

SPOCT HR – Product Description 22

Columbia University Pipeline Products & Ongoing Clinical Trials Overview 23

Optical Coherence Tomography System – Product Status 23

Optical Coherence Tomography System – Product Description 23

Compact Imaging Inc. Pipeline Products & Ongoing Clinical Trials Overview 24

MRO Optical Imaging Sensor – Product Status 24

MRO Optical Imaging Sensor – Product Description 24

Costruzioni Strumenti Oftalmici Cso Srl Pipeline Products & Ongoing Clinical Trials Overview 25

MD-SD-OCT Instrument – Product Status 25

MD-SD-OCT Instrument – Product Description 25

Digital Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 26

IDx – Glaucoma – Product Status 26

IDx – Glaucoma – Product Description 26

Duke University Pipeline Products & Ongoing Clinical Trials Overview 27

HH – SDOCT – Product Status 27

HH – SDOCT – Product Description 27

Microscope Integrated OCT System – Product Status 28

Microscope Integrated OCT System – Product Description 28

OCT Scanner – Product Status 28

OCT Scanner – Product Description 29

Whole Eye Optical Coherence Tomography Scanner – Product Status 29

Whole Eye Optical Coherence Tomography Scanner – Product Description 29

Duke University – Ongoing Clinical Trials Overview 30

Microscope Integrated OCT System – Optimize Pediatric OCT (Optical Coherence Tomography) Imaging: a Pilot Study 31

Whole Eye Optical Coherence Tomography Scanner – Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care 2 and School Age Follow on Study 32

George Washington University Pipeline Products & Ongoing Clinical Trials Overview 33

Amplified Bimorph Scanning Mirror System – Product Status 33

Amplified Bimorph Scanning Mirror System – Product Description 33

Heidelberg Engineering GmbH Pipeline Products & Ongoing Clinical Trials Overview 34

Cataract And Refractive Imaging Device – Product Status 34

Cataract And Refractive Imaging Device – Product Description 34

SPECTRALIS OCT2 Module – OCT Angiography – Product Status 35

SPECTRALIS OCT2 Module – OCT Angiography – Product Description 35

Kubota Vision Inc Pipeline Products & Ongoing Clinical Trials Overview 36

eyeMO – Product Status 36

eyeMO – Product Description 36

Kubota Vision Inc – Ongoing Clinical Trials Overview 37

eyeMO – A Prospective Study of Patient Based Ophthalmology Suite (PBOS), In-home Optical Coherence Tomography Device in Patients of Japan 38

Leica Microsystems GmbH Pipeline Products & Ongoing Clinical Trials Overview 39

DI-SDOCT Imaging System – Product Status 39

DI-SDOCT Imaging System – Product Description 39

SDOCT Scanner – Product Status 40

SDOCT Scanner – Product Description 40

LighTopTech Corp Pipeline Products & Ongoing Clinical Trials Overview 41

Gabor-Domain Optical Coherence Microscopy Imaging System – Product Status 41

Gabor-Domain Optical Coherence Microscopy Imaging System – Product Description 41

Lumedica Inc Pipeline Products & Ongoing Clinical Trials Overview 42

OCTA System – Product Status 42

OCTA System – Product Description 42

Optical Coherence Tomography System – Product Status 43

Optical Coherence Tomography System – Product Description 43

Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 44

Intraoperative Imaging Tool – Product Status 44

Intraoperative Imaging Tool – Product Description 44

MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 45

High Resolution OCT – Product Status 45

High Resolution OCT – Product Description 45

Intracranial OCT – Product Status 46

Intracranial OCT – Product Description 46

OCT+IVUS – Product Status 46

OCT+IVUS – Product Description 47

OCT+IVUS+FFR – Product Status 47

OCT+IVUS+FFR – Product Description 47

Peripheral OCT – Product Status 48

Peripheral OCT – Product Description 48

Moorfields Eye Hospital NHS Foundation Trust Pipeline Products & Ongoing Clinical Trials Overview 49

Binocular Optical Coherence Tomography – Product Status 49

Binocular Optical Coherence Tomography – Product Description 49

Myriad Advanced Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 50

Optical Coherence Tomography System – Product Status 50

Optical Coherence Tomography System – Product Description 50

Nippon Telegraph and Telephone Corp Pipeline Products & Ongoing Clinical Trials Overview 51

High – Speed Wavelength Swept Light – Based OCT Device – Product Status 51

High – Speed Wavelength Swept Light – Based OCT Device – Product Description 51

Notal Vision Inc Pipeline Products & Ongoing Clinical Trials Overview 52

Notal Home OCT System – Product Status 52

Notal Home OCT System – Product Description 52

Notal Vision Inc – Ongoing Clinical Trials Overview 53

Notal Home OCT System – Evaluation of Repeated, In-Clinic, Self-Imaging by DME Patients Using the Notal Vision 54

Notal Home OCT System – Home OCT Fluid Visualization Agreement Study at Multiple Retinal Clinics with Placement of One Home OCT Device in the Home of Each NV-AMD Subject in the US for 5 Weeks 54

Notal Home OCT System – Home OCT Guided Management Study of Subjects Diagnosed With Neovascular-AMD 54

Notal Home OCT System – Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD 55

Opticent Inc Pipeline Products & Ongoing Clinical Trials Overview 56

Aurora X3 – Product Status 56

Aurora X3 – Product Description 56

SS-vis-OCT – Product Status 57

SS-vis-OCT – Product Description 57

OptoQuest Inc Pipeline Products & Ongoing Clinical Trials Overview 58

Vectralis – Product Status 58

Vectralis – Product Description 58

Optos Plc Pipeline Products & Ongoing Clinical Trials Overview 59

Falcon I – Product Status 59

Falcon I – Product Description 59

Falcon II – Product Status 60

Falcon II – Product Description 60

Lotte – Product Status 60

Lotte – Product Description 61

OptoVibronex LLC Pipeline Products & Ongoing Clinical Trials Overview 62

OptoScope 2.0 – Product Status 62

OptoScope 2.0 – Product Description 62

Optovue Inc Pipeline Products & Ongoing Clinical Trials Overview 63

Intelligent OCT Retinal Disease Screening System – Product Status 63

Intelligent OCT Retinal Disease Screening System – Product Description 63

Oregon Health & Science University Pipeline Products & Ongoing Clinical Trials Overview 64

OCTA Test – Product Status 64

OCTA Test – Product Description 64

Physical Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 65

AO-OCT System – Product Status 65

AO-OCT System – Product Description 65

Rowiak GmbH Pipeline Products & Ongoing Clinical Trials Overview 66

Pencil OCT – Product Status 66

Pencil OCT – Product Description 66

Singapore Eye Research Institute Pipeline Products & Ongoing Clinical Trials Overview 67

Polarization Sensitive Optical Coherence Tomography (PS-OCT) Device – Product Status 67

Polarization Sensitive Optical Coherence Tomography (PS-OCT) Device – Product Description 67

Sinoora Inc. Pipeline Products & Ongoing Clinical Trials Overview 68

On-chip Spectral Coherence Tomography System – Product Status 68

On-chip Spectral Coherence Tomography System – Product Description 68

The University of Texas at Austin Division of Housing and Food Service Pipeline Products & Ongoing Clinical Trials Overview 69

Non-Invasive Detection System – Product Status 69

Non-Invasive Detection System – Product Description 69

Theia Imaging LLC Pipeline Products & Ongoing Clinical Trials Overview 70

300 kHz OCT System – Product Status 70

300 kHz OCT System – Product Description 70

Theia 2 System – Product Status 71

Theia 2 System – Product Description 71

Theia Imaging LLC – Ongoing Clinical Trials Overview 72

300 kHz OCT System – Optimize Pediatric OCT (Optical Coherence Tomography) Imaging: a Pilot Study 73

TowardPi Medical Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview 74

Digital Navigation Microscope – Product Status 74

Digital Navigation Microscope – Product Description 74

Tupai (Beijing) Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 75

Ophthalmic OCT Device – Product Status 75

Ophthalmic OCT Device – Product Description 75

University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview 76

Directional Optical Coherence Tomography Device – Product Status 76

Directional Optical Coherence Tomography Device – Product Description 76

University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 77

Multimodal OCT Device – Product Status 77

Multimodal OCT Device – Product Description 77

University of Liverpool Pipeline Products & Ongoing Clinical Trials Overview 78

Ultra-Sensitive Optical Coherence Tomography system – Product Status 78

Ultra-Sensitive Optical Coherence Tomography system – Product Description 78

University of Louisville Pipeline Products & Ongoing Clinical Trials Overview 79

Diagnostic System – Diabetic Retinopathy – Product Status 79

Diagnostic System – Diabetic Retinopathy – Product Description 79

University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 80

Automated Optic Nerve Head Assessment System – Product Status 80

Automated Optic Nerve Head Assessment System – Product Description 80

University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 81

Scanning Optical System – Product Status 81

Scanning Optical System – Product Description 81

Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 82

Optical Imaging System – Retinal Disease – Product Status 82

Optical Imaging System – Retinal Disease – Product Description 82

Glossary 87

Figures

Optical Coherence Tomography (OCT) – Pipeline Products by Stage of Development 11

Optical Coherence Tomography (OCT) – Pipeline Products by Territory 12

Optical Coherence Tomography (OCT) – Pipeline Products by Regulatory Path 13

Optical Coherence Tomography (OCT) – Pipeline Products by Estimated Approval Date 14

Optical Coherence Tomography (OCT) – Ongoing Clinical Trials 15

Frequently asked questions

Optical Coherence Tomography (OCT) Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

Most Popular
$8,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Optical Coherence Tomography (OCT) Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Optical Coherence Tomography (OCT) reports
Medical Devices
New
Medical Devices M&A Deals H1 2026 - Top Themes: Strategic…
$495 | July 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Medical Devices
New
Traditional Wound Management Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | June 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Optical Coherence Tomography (OCT) Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Optical Coherence Tomography (OCT) Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more